Atlas Trials

Zafgen, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zafgen, Inc.

RecordFirmDate
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes (NCT03254368)Zafgen, Inc.2017-09-12
An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus (NCT02324491)Zafgen, Inc.2014-12-01
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome (NCT02179151)Zafgen, Inc.2014-09-01
An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury (NCT02063295)Zafgen, Inc.2014-04-01
An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome (NCT01818921)Zafgen, Inc.2013-06-01
An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects (NCT01666691)Zafgen, Inc.2012-08-01
ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity (NCT01507077)Zafgen, Inc.2011-12-01
Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers (NCT01372761)Zafgen, Inc.2011-06-01
Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers (NCT01028261)Zafgen, Inc.2009-12-01

Track Zafgen, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.